D. Medical Industries LTD (DMED) – Press Releases
-
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
-
DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
-
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
-
DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution
-
DiagnaMed Announces Listing on OTCQB in the United States
-
DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product
-
DiagnaMed Announces Application for OTCQB Listing
-
DiagnaMed Enters into License Agreement with University of Miami for Brain Health Platform for Integration with CERVAI™, a Brain Health AI Platform Leveraging Generative AI
-
DiagnaMed Prioritizes Development and Commercialization Initiatives for CERVAI™, a Brain Health AI Platform Leveraging Generative AI
-
DiagnaMed Announces Appointment of New Director
-
DiagnaMed Holdings Incorporates OpenAI’s ChatGPT into BRAIN AGE™ AI Product Suite
-
DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023
-
DiagnaMed Holdings Acquires Exclusive Rights to a Virtual Reality and Artificial Intelligence-based Neurodiagnostic System for Neurodegenerative Disease
-
DiagnaMed Holdings Announces Listing on the Canadian Securities Exchange
Back to DMED Stock Lookup